Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases
Siqin He, Jiajia Gui, Kun Xiong, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Advances and future perspectives of intranasal drug delivery: A scientometric review
Dong Xu, Xujiao Song, Xue Chen, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 366-384
Closed Access | Times Cited: 19
Fatal COVID-19 pulmonary disease involves ferroptosis
Baiyu Qiu, Fereshteh Zandkarimi, Anjali Saqi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
Yongjiang Li, Junyong Wu, Xiaohan Qiu, et al.
Bioactive Materials (2022) Vol. 20, pp. 548-560
Open Access | Times Cited: 63
mRNA nanodelivery systems: targeting strategies and administration routes
Mujie Yuan, Zeyu Han, Yan Liang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 31
Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies
Sachin S. Gaikwad, Snehal R. Pathare, Mayur A. More, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 292-311
Closed Access | Times Cited: 29
A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip
Arunima Sengupta, Aurélien Dorn, Mohammad Jamshidi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Cell-mediated nanoparticle delivery systems: towards precision nanomedicine
Ruoyu Cheng, Shiqi Wang
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 11, pp. 3032-3054
Open Access | Times Cited: 12
Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications
Saniya Alwani, Ellen K. Wasan, Ildikó Badea
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3084-3102
Closed Access | Times Cited: 8
Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (1998–2024)
Yu Cao, Chunhai Fan, Y. Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Current trends in inhaled pharmaceuticals: challenges and opportunities in respiratory infections treatment
Kiramat Ali Shah, Anam Razzaq, Amos Dormocara, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access | Times Cited: 1
A Universal Chemotactic Targeted Delivery Strategy for Inflammatory Diseases
Ting Li, Zhiyong Liu, Jinglei Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 47
Closed Access | Times Cited: 34
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals
Fakhrossadat Emami, Mahsa Keihan Shokooh, Seyed Jamaleddin Mostafavi Yazdi
Journal of Pharmaceutical Investigation (2022) Vol. 53, Iss. 1, pp. 35-57
Open Access | Times Cited: 32
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
Mahesh Kumar, Tarun Virmani, Girish Kumar, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1360-1360
Open Access | Times Cited: 22
Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery
Thiago Medeiros Zacaron, Mariana Leite Simões e Silva, Mirsiane Pascoal Costa, et al.
Polymers (2023) Vol. 15, Iss. 18, pp. 3849-3849
Open Access | Times Cited: 21
An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management
Hitesh Chopra, Yugal Kishore Mohanta, Pradipta Ranjan Rauta, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 581-581
Open Access | Times Cited: 20
Nanosized Drug Delivery Systems to Fight Tuberculosis
Tom Bourguignon, Jesus Alfredo Godinez-Leon, Ruxandra Gref
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 393-393
Open Access | Times Cited: 18
Aerosol pulmonary immune engineering
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114831-114831
Open Access | Times Cited: 18
A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases
Fabian Bohländer
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy
Yang‐Bao Miao, Tianxing Xu, Ying Gong, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Recent advances in the therapeutic potential of nobiletin against respiratory diseases
Yanqin Qin, Jingfan Yang, Haibo Li, et al.
Phytomedicine (2024) Vol. 128, pp. 155506-155506
Open Access | Times Cited: 7
Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters
Liuhan Dong, Xiaomei Zhuang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4671-4671
Open Access | Times Cited: 6
A review on micro and nanoengineering in Powder-Based pulmonary drug delivery
L. Paséro, Francesca Susa, Tania Limongi, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124248-124248
Open Access | Times Cited: 6
Size-Controlled Preparation of Docetaxel- and Curcumin-Loaded Nanoemulsions for Potential Pulmonary Delivery
Azren Aida Asmawi, Norazlinaliza Salim, Emilia Abdulmalek, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 652-652
Open Access | Times Cited: 14
Non-spherical drug particle deposition in human airway using computational fluid dynamics and discrete element method
Sorathan Tanprasert, Chanida Kampeewichean, Shuichi Shiratori, et al.
International Journal of Pharmaceutics (2023) Vol. 639, pp. 122979-122979
Closed Access | Times Cited: 13
Immunometabolic reprogramming of macrophages with inhalable CRISPR/Cas9 nanotherapeutics for acute lung injury intervention
Wanling Huang, Gaohong Fu, Yangeng Wang, et al.
Acta Biomaterialia (2024) Vol. 181, pp. 308-316
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top